CD8A and neoplasm: We did not observe a change in PD‐1 expression (marker of exhaustion) in bulk CD8 T cells throughout the CCl4 protocol (data not shown), suggesting exhaustion may not be the underlying reason for lack of tumour control or delayed response to immunotherapy.